These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 29689671)

  • 1. [[Evaluation of four methods for the detection of ESBL-producing enterobacteria]].
    Acosta-Pérez G; Rodríguez-Abrego G; Castro-Mussot ME
    Salud Publica Mex; 2018; 60(1):106-107. PubMed ID: 29689671
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
    Zarakolu P; Metan G; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phenotypic and molecular identification of extended-spectrum beta-lactamase (ESBL) TEM and SHV produced by clinical isolates Escherichia coli and Klebsiella spp. in hospitals].
    González Mesa L; Ramos Morí A; Nadal Becerra L; Morffi Figueroa J; Hernández Robledo E; Alvarez AB; Marchena Bequer JJ; González Alemán M; Villain Plous C
    Rev Cubana Med Trop; 2007; 59(1):52-8. PubMed ID: 23427419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of cefepime, cefotaxime, ceftazidime, and aztreonam against extended-spectrum-producing isolates of Klebsiella pneumoniae and Escherichia coli from Chilean hospitals.
    Zemelman C; Bello H; Domínguez M; González G; Mella S; Zemelman R
    Diagn Microbiol Infect Dis; 2001; 40(1-2):41-3. PubMed ID: 11448562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Duttaroy B; Mehta S
    Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
    Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faecal colonization of E. coli and Klebsiella spp. producing extended-spectrum beta-lactamases and plasmid-mediated AmpC in Mozambican university students.
    Chirindze LM; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Sundsfjord A; Essack SY; Simonsen GS
    BMC Infect Dis; 2018 May; 18(1):244. PubMed ID: 29843632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefpodoxime screening of Escherichia coli and Klebsiella spp. by Vitek for detection of organisms producing extended-spectrum beta-lactamases.
    Gibb AP; Crichton M
    Diagn Microbiol Infect Dis; 2000 Dec; 38(4):255-7. PubMed ID: 11146252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nosocomial and community infections due to class A extended-spectrum β-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil.
    Wollheim C; Guerra IM; Conte VD; Hoffman SP; Schreiner FJ; Delamare AP; Barth AL; Echeverrigaray S; Costa SO
    Braz J Infect Dis; 2011; 15(2):138-43. PubMed ID: 21503400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
    World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an urban hospital in Dhaka, Bangladesh.
    Rahman MM; Haq JA; Hossain MA; Sultana R; Islam F; Islam AH
    Int J Antimicrob Agents; 2004 Nov; 24(5):508-10. PubMed ID: 15519486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicament in Detection and Reporting of Extended Spectrum Beta Lactamase Production in Routine Antibiotic Susceptibility Testing.
    Butt T; Raza S; Butt E
    J Coll Physicians Surg Pak; 2017 Dec; 27(12):788-790. PubMed ID: 29185411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the current National Committee for Clinical Laboratory Standards guidelines for screening and confirming extended-spectrum beta-lactamase production in isolates of Escherichia coli and Klebsiella species from bacteremic patients.
    Katz OT; Peled N; Yagupsky P
    Eur J Clin Microbiol Infect Dis; 2004 Nov; 23(11):813-7. PubMed ID: 15480883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins.
    Jett BD; Ritchie DJ; Reichley R; Bailey TC; Sahm DF
    Antimicrob Agents Chemother; 1995 May; 39(5):1187-90. PubMed ID: 7625813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung colonization with Enterobacteriaceae producing extended-spectrum beta-lactamases in cystic fibrosis patients.
    Cantón R; Morosini MI; Ballestero S; Alvarez ME; Escobar H; Máiz L; Baquero F
    Pediatr Pulmonol; 1997 Sep; 24(3):213-7. PubMed ID: 9330418
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of extended-spectrum beta-lactamases by using boronic acid as an AmpC beta-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli.
    Song W; Bae IK; Lee YN; Lee CH; Lee SH; Jeong SH
    J Clin Microbiol; 2007 Apr; 45(4):1180-4. PubMed ID: 17301276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of CTX-M group I and group III β-lactamases produced by Escherichia coli and klebsiella pneumoniae in Lahore, Pakistan.
    Abrar S; Vajeeha A; Ul-Ain N; Riaz S
    Microb Pathog; 2017 Feb; 103():8-12. PubMed ID: 27956216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
    Akyar I
    Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.